R&D Sponsored 12 Questions with Matthew Goodman LUCENT Biopharma's Medical Director Matthew Goodman, a doctor by training, specialises in late-phase Clinical Development and Medical Affairs.
Digital Accelerating the medical wheel with AI: From engagement to i... Explore an AI-powered 360 Medical Engagement vision that links engagement, insight, evidence, and strategy in a continuous loop.
Sales & Marketing Breaking tradition to reimagine medical affairs workflows fo... To stay relevant, medical affairs teams must adapt how they work to meet new demands with greater agility and efficiency.
Sales & Marketing Sponsored Bridging science and strategy: Medical Affairs at the heart ... In this sponsored podcast, Cheryl Lubbert and Carolyn Whiting of Reverba discuss a new approach to pharma marketing, omnichannel, and medical affairs.
Sales & Marketing Omnichannel: Redesigning customer engagement to improve pati... Omnichannel is a seamless, personalised experience that bridges the traditional divide between Medical Affairs and Commercial teams.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.